COST-EFFECTIVENESS OF CARDIAC RESYNCHRONISATION THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE HEART FAILURE

被引：0
|
作者：
Neyt, M. [1 ]
Stroobandt, S. [1 ]
Obyn, C. [1 ]
Camberlin, C. [1 ]
Devriese, S. [1 ]
De Laet, C. [1 ]
Van Brabandt, H. [1 ]
机构：
[1] Belgian Hlth Care Knowledge Ctr, Brussels, Belgium
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.121
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A253 / A253
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF TOFACTINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER CONVENTIONAL THERAPY IN SPAIN
    Taxonera, C.
    de Andres-Nogales, F.
    Garcia, S.
    Sanchez-Guerrero, A.
    Menchen, B.
    Peral, C.
    Cabez, A.
    Gomez, S.
    Lopez, A.
    Casado, M. A.
    Menchen, L.
    VALUE IN HEALTH, 2019, 22 : S619 - S619
  • [32] COST-EFFECTIVENESS OF VEDOLIZUMAB FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS IN THAILAND
    Sruamsiri, R.
    VALUE IN HEALTH, 2018, 21 : S2 - S2
  • [33] Cost-Effectiveness of Supervised Exercise Therapy in Heart Failure Patients
    Kuehr, Eduardo M.
    Ribeiro, Rodrigo A.
    Rohde, Luis Eduardo P.
    Polanczyk, Carisi A.
    VALUE IN HEALTH, 2011, 14 (05) : S100 - S107
  • [34] Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis
    Wu, Bin
    Wang, Zhenhua
    Zhang, Qiang
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2291 - 2302
  • [35] COST-EFFECTIVENESS OF USTEKINUMAB IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN MEXICO
    Valencia-Mendoza, A.
    Hernandez-Garduno, A.
    Puig, A.
    VALUE IN HEALTH, 2012, 15 (07) : A513 - A514
  • [36] Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China
    Kim, Soyoung
    Ooi, Adrian Yit Reen
    Stephens, Thomas
    Jiang, Hongsi
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1125 - 1141
  • [37] Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective
    Igarashi, Atsuyuki
    Igarashi, Ataru
    Graham, Christopher N.
    Gilloteau, Isabelle
    Tani, Yumiko
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (01) : 7 - 15
  • [38] Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
    Jia, Xiaoying
    Zhao, Yang
    Carrico, Justin
    Brodtkorb, Thor-Henrik
    Mendelsohn, Alan M.
    Lowry, Simon
    Feldman, Steve
    Wu, Jashin J.
    Armstrong, April W.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 740 - 748
  • [39] COST-EFFECTIVENESS OF SEQUENCES OF BIOLOGIC TREATMENTS FOR MODERATE-TO-SEVERE PSORIASIS IN FINLAND
    Asseburg, C.
    Valgardsson, S.
    Soini, E. J.
    VALUE IN HEALTH, 2013, 16 (07) : A507 - A508
  • [40] COST EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY (CRT) FOR MILD TO MODERATE HEART FAILURE
    Wells, G. A.
    Coyle, D.
    Coyle, K.
    Talajic, M.
    Tang, A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S419 - S419
12345